Safety evaluation of desloratadine in allergic rhinitis

By González-Núñez Vanesa  

Expert Opinion on Drug Safety, Vol. 12, Iss. 3, 2013-05 ,pp. : 445-453

Informa Healthcare

Access to resources Recommend Favorite

Review of desloratadine for the treatment of allergic rhinitis, chronic idiopathic urticaria and allergic inflammatory disorders

By DuBuske Lawrence M  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2511-2523

Informa Healthcare

Access to resources Recommend Favorite

Safety and Efficacy of Desloratadine in Subjects with Seasonal Allergic Rhinitis or Chronic Urticaria: Results of Four Postmarketing Surveillance Studies

By Bachert Claus  

Clinical Drug Investigation, Vol. 30, Iss. 2, 2010-02 ,pp. : 109-122

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Once-Daily 5mg Desloratadine, an H-Receptor Antagonist, in Patients with Seasonal Allergic Rhinitis: Assessment during the Spring and Fall Allergy Seasons

By Meltzer E.O.  

Clinical Drug Investigation, Vol. 21, Iss. 1, 2001-01 ,pp. : 25-32

Adis International

Access to resources Recommend Favorite

Desloratadine - first clinical data in rhinitis revealed

By  

Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite